Informed Medical Consent

Last updated: February 2026

1. About this document

This document explains what you are consenting to when you undergo an ADHD assessment or receive treatment through Dopa. We believe informed consent means you fully understand the process, its limitations, and your rights at every stage.

2. Assessment process

Your assessment includes pre-appointment questionnaires and a 90-minute video consultation with a specialist clinician. The clinician will review your developmental history, current symptoms, and functional impact. You may be asked to provide collateral information (e.g. school reports, input from a family member).

3. Diagnosis

A diagnosis of ADHD is not guaranteed. The clinician will make a clinical judgement based on DSM-5/ICD-11 criteria. You will receive a written report regardless of the outcome. If ADHD is not diagnosed, alternative explanations or referrals may be suggested.

4. Medication

If medication is recommended, your clinician will explain the benefits, risks, and side effects. ADHD medications are controlled substances and require regular monitoring. You have the right to decline medication at any point. Titration involves gradual dose adjustment with regular check-ins to find the right balance.

5. GP communication

We do not currently offer shared care arrangements. Your diagnostic report is yours to share with your GP if you choose. We can provide a copy of your report for this purpose upon request. All prescribing and ongoing care remains with Dopa for the duration of your treatment with us.

6. Your rights

You can withdraw consent and discontinue treatment at any time. You have the right to a second opinion. You can request your full medical records. You can raise concerns through our complaints process or directly with the CQC.

7. Contact

If you have any questions about consent or the clinical process, contact clinical@dopa.co.uk.